GoodRx Holdings, Inc. Interest Expense Nonoperating
GoodRx Holdings, Inc. (GDRX) reported Interest Expense Nonoperating of $9.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-05
- GoodRx Holdings, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $9.81M, a 8.57% decline year-over-year.
- GoodRx Holdings, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $9.77M, a 8.24% decline year-over-year.
- GoodRx Holdings, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $10.40M, a 8.41% decline year-over-year.
- GoodRx Holdings, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $10.83M, a 12.35% decline year-over-year.
- GoodRx Holdings, Inc. interest expense nonoperating for fiscal 2025 was $42.60M, a 19.49% decline from fiscal 2024.
- GoodRx Holdings, Inc. interest expense nonoperating for fiscal 2024 was $52.92M, a 6.71% decline from fiscal 2023.
- GoodRx Holdings, Inc. interest expense nonoperating for fiscal 2023 was $56.73M, a 65.66% increase from fiscal 2022.
- GoodRx Holdings, Inc. interest expense nonoperating for fiscal 2022 was $34.24M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.81M 10-Q · filed 2026-08-05 | $19.58M 10-Q · filed 2026-08-05 | $29.98M derived: sum of 3 quarters · filed 2026-08-05 | $40.81M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $9.77M 10-Q · filed 2026-05-06 | $20.17M derived: sum of 2 quarters · filed 2026-05-06 | $31.00M derived: sum of 3 quarters · filed 2026-05-06 | $41.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.23M derived: sum of 2 quarters · filed 2026-02-26 | $31.96M derived: sum of 3 quarters · filed 2026-08-05 | $42.60M 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.83M 10-Q · filed 2025-11-04 | $21.56M derived: sum of 2 quarters · filed 2026-08-05 | $32.20M 10-Q · filed 2025-11-04 | $43.56M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $10.73M 10-Q · filed 2026-08-05 | $21.37M 10-Q · filed 2026-08-05 | $32.73M derived: sum of 3 quarters · filed 2026-08-05 | $45.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $10.64M 10-Q · filed 2026-05-06 | $22.00M derived: sum of 2 quarters · filed 2026-05-06 | $34.36M derived: sum of 3 quarters · filed 2026-05-06 | $48.92M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.71M derived: sum of 2 quarters · filed 2026-02-26 | $38.28M derived: sum of 3 quarters · filed 2026-02-26 | $52.92M 10-K · filed 2026-02-26 |
| 2024-09-30 | $12.36M 10-Q · filed 2025-11-04 | $26.92M derived: sum of 2 quarters · filed 2025-11-04 | $41.56M 10-Q · filed 2025-11-04 | $56.38M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $14.57M 10-Q · filed 2025-08-06 | $29.21M 10-Q · filed 2025-08-06 | $44.03M derived: sum of 3 quarters · filed 2026-02-26 | $58.75M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $14.64M 10-Q · filed 2025-05-07 | $29.46M derived: sum of 2 quarters · filed 2026-02-26 | $44.18M derived: sum of 3 quarters · filed 2026-02-26 | |
| 2023-12-31 | $14.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $29.54M derived: sum of 2 quarters · filed 2026-02-26 | $56.73M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $14.72M 10-Q · filed 2024-11-07 | $41.91M 10-Q · filed 2024-11-07 | ||
| 2022-12-31 | $34.24M 10-K · filed 2025-02-27 |